Administration of ADM to transgenic mice restored early insulin resistance in adipose tissue by inhibiting adipocyte major histocompatibility complex class II (MHC II) antigen presentation and CD4 (+) T cell activation [43]. This evidence concerns the gene CD4 and Insulin resistance.